Clinical and Demographic Characteristics of the Patients Who Had Normal ALT at Study Entry and Developed Moderate ALT Increase During Follow-up
| Patient No. . | Sex/Age yr . | Duration of Follow-up (mo) . | ALT (U/L) . | Ferritin (ng/mL) . | |||
|---|---|---|---|---|---|---|---|
| Baseline Values* Median (range) . | Peak Value . | Follow-up Values-151 Median (range) . | 1992-1993 . | 1995-1996 . | |||
| 1 | M/1 | 33 | 20 (17-35) | 196 | 53 (29-201) | 780 | 2,210 |
| 2 | M/8 | 35 | 19 (17-34) | 141 | 36 (28-40) | 3,300 | 2,330 |
| 3 | M/2 | 32 | 25 (21-36) | 305 | 142 (110-247) | 500 | 2,620 |
| 4 | M/8 | 36 | 23 (18-32) | 151 | 32 (29-34) | 1,600 | 1,320 |
| 5 | M/6 | 35 | 21 (17-29) | 229 | 25 (12-56) | 1,960 | 2,330 |
| 6 | F/6 | 35 | 11 (7-12) | 348 | 16 (11-30) | 990 | 1,460 |
| 7 | M/1 | 35 | 24 (19-34) | 264 | 41 (17-230) | 260 | 2,260 |
| Patient No. . | Sex/Age yr . | Duration of Follow-up (mo) . | ALT (U/L) . | Ferritin (ng/mL) . | |||
|---|---|---|---|---|---|---|---|
| Baseline Values* Median (range) . | Peak Value . | Follow-up Values-151 Median (range) . | 1992-1993 . | 1995-1996 . | |||
| 1 | M/1 | 33 | 20 (17-35) | 196 | 53 (29-201) | 780 | 2,210 |
| 2 | M/8 | 35 | 19 (17-34) | 141 | 36 (28-40) | 3,300 | 2,330 |
| 3 | M/2 | 32 | 25 (21-36) | 305 | 142 (110-247) | 500 | 2,620 |
| 4 | M/8 | 36 | 23 (18-32) | 151 | 32 (29-34) | 1,600 | 1,320 |
| 5 | M/6 | 35 | 21 (17-29) | 229 | 25 (12-56) | 1,960 | 2,330 |
| 6 | F/6 | 35 | 11 (7-12) | 348 | 16 (11-30) | 990 | 1,460 |
| 7 | M/1 | 35 | 24 (19-34) | 264 | 41 (17-230) | 260 | 2,260 |
*Values observed during the first 6 months of follow-up.
Values observed after the ALT flare-up.